IPO pitch puts BrainAurora’s earnings under the microscope
The provider of digital diagnostics and therapies has linked up with Chinese hospitals to detect conditions such as Alzheimer’s and brain trauma, but the business has yet to turn a…
Recent Articles
RELATED ARTICLES
-
A blockbuster cancer drug? TYK’s claims go under the microscope
2410.HK -
BRIEF: BrainAurora opens flat in Hong Kong trading debut
6681.HK
- Why aim small? 51World Digital Twin sets its sights on cloning Earth
-
Airdoc Tech enjoys healing properties of medical AI rally
2251.HK
-
CARsgen seeks cell therapy breakthrough but stays in the red for now
2171.HK
- Shanghai Able’s renewed IPO plan hobbled by weak appetite for new tech listings
-
Cancer drug maker Biostar shines on Hong Kong market debut
2563.HK
